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Identification of New Antigenic Sites of GII.4 Noroviruses 127 128
To pinpoint the role of each amino acid within the P domain in the evolution of GII.4, we 129 calculated the Shannon Entropy to measure the residue diversity at the inter-variant and intra-130 variant level. Because Grimsby-like viruses were the first recorded to cause large outbreaks 131 worldwide, entropy values were calculated with strains (1572 VP1 sequences) detected from 132 1995 to 2016. While minimal diversity was detected at the intra-variant level (Fig. S3 ), the inter-133 variant level revealed three substitution patterns: (i) a large number (87%, 285/325) of highly 134 conserved residues, which include conserved antigenic site F (27), and likely maintain the 135 structural integrity of the P domain; (ii) a small number (5%, 17/325) of variable residues that 136 map on the previously determined antigenic sites: A-E (19); and (iii) 23 variable residues that 137 map outside of those antigenic sites ( Fig. 2a ). Among the 23 non-antigenic variable sites from 138 the third pattern, two residues (residues 228 and 255) were surrounded by conserved residues on 139 the surface of VP1, and fourteen residues formed clusters (motifs) on the surface that could 140 represent new, or extensions of previously predicted, uncharacterized antigenic sites ( Fig. 2b) . 141
One motif comprises residues 339, 340, 341, 375, 376, 377, and 378. Because this motif included 142 two residues (340 and 376) previously described as one of the five major antigenic sites (20), we 143 extended the number of residues forming this antigenic site C (Fig. 2b) . Although residue 375 144 presented low variability, the site was included as part of the antigenic site as it mapped on the 145 surface of the molecule and could potentially play a role in antibody recognition. Antigenic site 146 D was also extended to include two additional residues (396 and 397), as they clustered with 147 original residues (393, 394, and 395) on the surface (19). The new motif, denominated G, 148 8 included residues 352, 355, 356, 357, 359, and 364 ; and the last motif, denominated H, included 149 the residues 309 and 310. A summary of the residues from each of the motifs/antigenic sites is 150 shown in Fig. 2b . Profiling of the temporal frequency of the amino acid sequence pattern 151 (mutational pattern) of the previously characterized antigenic site A, the expanded antigenic site 152 C, and the new antigenic site G (confirmed in this study) indicated that their mutational patterns 153 correlated well with the fluctuation of GII.4 variants in the human population, suggesting a major 154 role in the emergence of variants ( Fig. 3 and Fig. S4a ). Correlation between the antigenic site 155 mutational patterns and GII.4 variants was assessed using adjusted Rand Index, and antigenic 156 site G was the one presenting the best correlation with the GII.4 variant circulation pattern, while 157
showing low sequence variation ( Fig. 3b and c) . Of note is that the mutational pattern from the 158 old antigenic site C did not correlate with the circulation of variants in nature ( Fig. S4a and b) , 159
suggesting that our population-guided antigenic site characterization provides a better resolution 160 of the antigenic profiling of GII.4 noroviruses. Neither the previously defined putative epitope 161 with the recent addition of residue 396 to this antigenic site (29). On the contrary, the mutational 9 pattern from the expanded antigenic site E showed lower correlation than that from the original 172 antigenic site ( Fig. S4a and b ). This could be due to the expanded site (inclusion of residue 414) 173
showing variation within the variants, Den Haag 2006b and Sydney 2012, making the profiles 174 less consistent with the inter-variant diversity. Since our dataset presents sampling bias, i.e. over 175 50% of the sequences in the dataset were collected during 2010-2016, the Shannon entropy 176 analysis was re-conducted using a randomly-subsampled dataset that includes a maximum of 50 177 sequences per variant ( Fig. S5a ). This dataset sensitively reflected the variation of viruses 178 circulating before 2010, and showed 13 additional variable sites mapping outside the newly 179 defined variable motifs/antigenic sites. Only three of them were located on the surface of the 180 VP1; one of them (residue 250) did not cluster with any variable residues, and other two 181 (residues 300 and 329) mapped close to the motif/antigenic site G (Fig. S5b ). These two residues 182 could be a part of the antigenic site G, however, both presented minor variation over decades 183 suggesting a subtle impact on variant emergence ( Fig. S5c) . 184
185
The mutational patterns from three motifs (A, C, and G) correlated well with the fluctuation of 186 GII.4 variants (Fig. 3c ). The motif/antigenic site A was previously confirmed as an antigenic site 187 (23), while expanded/new motifs (C and G) were not yet confirmed experimentally. To confirm 188 the role of these two motifs in the antigenic make-up of the GII.4 capsid, we replaced residues of 189 the VP1 from a and vice versa, and produced the corresponding VLPs. We tested the mutant and wild-type VLPs 192 against guinea pig hyper-immune sera and mouse mAbs (two uncharacterized mAbs: B11 and 193 B12 raised against Farmington Hills 2002 variant (MD2004 strain) (11), and four mAbs: 1C10, 10 6E6, 17A5 and 18G12 newly developed against Sydney 2012 variant (RockvilleD1 strain)). We 195 found that mutations at the new motifs C and G abrogated binding of mAbs B11, B12, 6E6, 196 18G12, and mAbs 1C10 and 17A5, respectively ( Fig. 4a ). Reconstitution of the motif C in the 197 Sydney 2012 wild-type strain can be achieved by reverting those sites to Farmington Hills 2002 198 wild-type strain (2012: C2004 VLPs) ( Fig. 4a , left panel). Of note, when mutations were 199 introduced at residues 340 and 376, which were regarded as the original antigenic site C, no 200 differences in binding were observed with mAb B11 and B12 (11). While changes at residues 201 377 and 378 reduced binding to those mAbs, an additional mutation at residue 340 was required 202 for complete antigenic site-depletion ( This, together with the phylogenetic analyses, suggests that each pandemic variant presented a 249 different origin and did not follow a trunk-like linear evolution such as that seen in H3N2 250 influenza viruses (30). 251
252
Differences in the inter-and intra-variant evolutionary pattern were also confirmed by the 253 Bayesian Markov Chain Monte Carlo (MCMC) analysis. Substitution rates from seven variants 254 with > 50 sequences were calculated and summarized in Table 1 . The rate of inter-variant 255 (overall) GII.4 strains was reported elsewhere (15). Intra-variant substitution rates ranged from 256 1.57 -4.64 × 10 -3 substitutions/site/year, all of them lower than the inter-variant (overall) 257 substitution rate (5.4 × 10 -3 substitutions/site/year) (15). Among the variants, Sydney 2012 258 variants had the higher substitution rate (Table 1) . 259 Because different factors seemed to drive the inter-variant (overall) and intra-variant evolution, 263
we performed selection analysis using the Mixed Effect Model of Evolution (MEME) method 264 and looked for evidence of site-by-site episodic diversifying pressure on the VP1 along the 265 branches of its evolutionary tree. To analyze the overall evolutionary process, we randomly 266 most of the diversifying pressure was found on the branches connecting to the tips rather than on 276 the internal branches ( Fig. S8 ), suggesting that non-synonymous substitutions were deleterious 277 and rarely fixed in the population during the intra-variant evolution. The more comprehensive 278 dataset presented by New Orleans and Sydney variants may have included many viruses with 279 deleterious mutations that would not persist (as indicated by higher number of non-synonymous 280 substitutions on branches connecting to the tips), but would account for an artificial higher 281 substitution rate as compared with the other variants (Table 1 ). Together, this shows that the 282 diversifying pressure has driven the inter-variant, but not the intra-variant, evolution of GII.4 283 strains. GII.4 over all other norovirus genotypes has been explained by the chronological emergence of 291 variants, which enables the virus to evade the immunity acquired to previously-circulating GII.4 292 variants, a process similar to H3N2 influenza viruses (26, 28, 30). Since the mid-1990s, over 10 293 different variants have been reported, with six of them associated with large outbreaks 294 worldwide. The overall evolutionary pattern of GII.4 viruses presents a strong linear 295 accumulation of amino acid substitutions during inter-variant diversification (15), with most 296 substitutions occurring in the P2 subdomain (28). Antigenic differences among variants have 297 been largely attributed to highly variable residues that map on the surface of the P domain, 298
leading to the identification of five (A-E) motifs that are part of GII.4-specific antigenic sites 299 (18-20). While the binding site was characterized for different GII.4 specific mAbs, the same 300 studies have reported numerous GII.4 specific mAbs whose binding sites have not been 301 determined (11, 12, 19, 23-25). Applying a population genomics approach we found new (or 302 expanded) motifs on the surface of the capsid that presented mutational patterns that correlates 303 with the circulation of GII.4 variants. The role of antigenicity of two of those motifs (antigenic 304 sites C and G) were confirmed with (previously) uncharacterized HBGA-blockade mAbs (B11 305 and B12), newly developed mAbs (1C10, 6E6, 17A5, and 18G12), and polyclonal sera from 306 guinea pigs immunized with wild-type VLPs. The antigenic site G presented the strongest 307 correlation with the emergence and circulation of new GII.4 variants, while being more 308 conserved when compared with other large antigenic sites (e.g. A, C, or E). This indicates that 309 newly discovered antigenic site G plays a pivotal role in shaping the GII.4 noroviruses into new 310 variants with pandemic potential. The antigenic site C is close to the previously-defined 311 antigenic site A, but substitutions on antigenic site A did not affect the binding of those mAbs 312 (11). Notably, competition analyses among different mAbs showed that mAbs B11 and B12 313 partially blocked interactions with mAbs mapping to antigenic site A (11), suggesting that this 314 new motif is part of an antigenic site that involves more than one epitope (at least antigenic sites 315 (Fig. S7) . Similarly, the NERK motif, which was 331 suggested to occlude conserved GII.4 antigenic sites and effect the antibody blockade potency 332 (33, 34), was shown to be highly conserved among GII.4 variants. Previous studies pointed out a 333 mutation on this motif in Sydney 2012 variant, however, our large-scale analysis showed that the 334 New Orleans variant was the only one showing -at the population level-any mutation at this 335 motif (Fig. S9) . Thus, the profiling of mutational patterns we implemented, which included the 336 use of a large number of sequences, could provide a better understanding on the role of 337 individual mutations on the circulation and predominance of the pandemic GII.4 variants. 338
Immunological analyses that include multiple different viruses from each of the pandemic 339 variants are needed to better delineate the meaning of minor mutations on the antigenic 340 differences among the variants. (15, 50-52). In the same context, we found six GII.4 strains that did not cluster with any GII.4 396 variant (Fig. S1) , and could represent strains that did not adapt well to the human population. 397
These strains presented different sequence patterns in their antigenic sites, and therefore could 398 constitute strains in the pre-pandemic stage that explored the sequence space but failed to thrive 399 to the next evolutionary level. 400 19 401
Our findings suggest two different mechanisms behind the evolutionary dynamics of the major 402 capsid protein from GII.4 noroviruses: (1) a steady pandemic phase governed by stochastic 403 processes, which is preceded by (2) substitutions that arise from positive selection. Our study 404 also provides a methodological framework that could facilitate the characterization of variable 405 antigenic sites that play a relevant role in the emergence of new viruses in the human population. (Table S1 ). The 417 sequences spanned 42 years from 1974 to 2016. Sequences were aligned using ClustalW as 418 implemented in MEGA v7 (53), and visually inspected to confirm proper alignment. 419
Nomenclature for GII.4 variants was adopted as previously indicated (15), and variant datasets 420 were parsed following such information. Sequence analyses were performed using total dataset 421 [PDB] accession number: 2OBS) was rendered using UCSF Chimera (version 1.11.2) (54). 431
Profiling of mutational patterns of motifs/antigenic sites was performed using R 3.4.2 (55). 432
Amino acid sequences of each motif/antigenic site was profiled by year and its mutational 433 patterns were plotted in a composite bar graph showing the number of strains with each pattern 434 as a fraction (%) of a whole (total number of strains). The correlation of the mutational patterns 435 and variant distribution was assessed using adjusted Rand Index, known as a clustering analysis 436 method, which evaluated the degree of the matches between mutational patterns and variant 437 classification. Adjusted Rand Index was calculated using R and mclust package (56). To account 438 for the sampling bias from the original dataset, we repeated entropy and structural analysis using 439 randomly subsampled dataset that included a maximum 50 strains/variant (n = 474) from the 440 original GII.4 dataset (1572 sequences). Information Criterion (AICc) as mentioned above. The clock models (strict or relaxed lognormal 466 clock) and tree priors (constant population size, exponential growth, or skyline) were tested, and 467 best models were selected based on the model selection procedure using AIC through MCMC. 468
The MCMC runs were performed until all the parameters reached convergence. MCMC runs 469 were analyzed using Tracer v1.6 (http://tree.bio.ed.ac.uk/software/tracer/). The initial 10% of the 470 logs from the MCMC run were removed before summarizing the mean and the 95% highest 471 posterior density interval of the substitution rates. Qiagen, Hilden, Germany). Introduction of mutations were confirmed by Sanger sequencing. 487
VLPs were produced using the Bac-to-Bac Baculovirus Expression System (Invitrogen, 488 California, USA) and purified through a cesium chloride gradient as previously described (63). 489
Expression of VP1 protein was confirmed by western blot, and VLP integrity was confirmed by 490 electron microscopy. 
